Trichomoniasis: Evaluation to execution

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 157, Issue 1, 2011, Pages 3-9

  Harp, Djana F ^a   Chowdhury, Indrajit ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Trichomoniasis

Indexed keywords

HYDROLASE; METRONIDAZOLE; ORNIDAZOLE; PROTEOME; SECNIDAZOLE; TINIDAZOLE;

ADAPTATION; EVALUATION; GENE EXPRESSION; GENETIC CONSERVATION; GENOME; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MULTIGENE FAMILY; NONHUMAN; PARASITE VIRULENCE; PATHOGENESIS; PENIS; PRIORITY JOURNAL; PROSTATE; REVIEW; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; SYMPTOM; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; TROPHOZOITE; URETHRA; UTERINE CERVIX; VAGINA;

EID: 79958804933     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.02.024     Document Type: Review

References (46)

1. McClelland RS. Trichomonas vaginalis infection: can we afford to do nothing? J Infect Dis 2008;197:487-9.
2. Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev 2009;22:37-45.
3. World Health Organization (WHO). Global prevalence and incidence of selected curable sexually transmitted infections. 2001. WHO/HIV-AIDS/2001.02/ CDC/CSR/EDC/2001.10.
4. Benchimol M. Trichomonads under microscopy. Microsc Microanal 2004; 10(5):528-50. (Pubitemid 39404017)
5. Sood S, Kapil A. An update on Trichomonas vaginalis. Indian J Sex Transm Dis 2008;29:7-14.
6. Sutak R, Dolezal P, Fiumera HL, et al. Mitochondrial-type assembly of FeS centers in the hydrogenosomes of the amitochondriate eukaryote Trichomonas vaginalis. Proc Natl Acad Sci USA 2004;101(28):10368-73. (Pubitemid 38924932)
7. Gomez C, Esther Ramirez M, Calixto-Galvez M, Medel O, Rodríguez MA. Regulation of gene expression in protozoa parasites. J Biomed Biotechnol 2010;2010:726045.
8. Carlton JM, Hirt RP, Silva JC, et al. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 2007;315:207-12. (Pubitemid 46166360)
9. Simoes-Barbosa A, Meloni D, Wohlschlegel JA, et al. Spliceosomal snRNAs in the unicellular eukaryote Trichomonas vaginalis are structurally conserved but lack a 50-cap structure. RNA 2008;14(8):1617-31.
10. Zubácová Z, Cimburek Z, Tachezy J. Comparative analysis of trichomonad genome sizes and karyotypes. Mol Biochem Parasitol 2008;161:49-54.
11. Lau AOT, Smith AJ, Brown MT, Johnson PJ. Trichomonas vaginalis initiator binding protein (IBP39) and RNA polymerase II large subunit carboxy terminal domain interaction. Mol Biochem Parasitol 2006;150(1):56-62. (Pubitemid 44349018)
12. Hirt RP, Noel CJ, Sicheritz-Ponten T, et al. Trichomonas vaginalis surface proteins: a view from the genome. Trends Parasitol 2007;23(11):540-7. (Pubitemid 350026472)
13. Vogel C, Chothia C. Protein family expansions and biological complexity. PLoS Comput Biol 2006;2(5):e48.
14. Fichorova RN, Trifonova RT, Gilbert RO, et al. Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 2006;74(10):5773-9. (Pubitemid 44484563)
15. Coombs GH, Westrop GD, Suchan P, et al. The amitochondriate eukaryote Trichomonas vaginalis contains a divergent thioredoxin-linked peroxiredoxin antioxidant system. J Biol Chem 2004;279:5249-56. (Pubitemid 38220544)
16. Hawkes S, Santhya KG. Diverse realities: sexually transmitted infections and HIV in India. Sex Transm Infect 2002;78(Suppl 1):i31-9. Erratum in: Sex Transm Infect 2005;81(3):282.
17. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev 2004;17(4):794-803.
18. Singh BN, Lucas JJ, Fichorova RN. Trichomonas vaginalis: pathobiology and pathogenesis. In: Khan NA, et al., editors. Emerging Protozoan Pathogens. London, UK: Taylor & Francis Group; 2007. p. 411-55.
19. Westrop GD, Goodall G, Mottram JC, et al. Cysteine biosynthesis in Trichomonas vaginalis involves cysteine synthase utilizing O-phosphoserine. J Biol Chem 2006;281(35):25062-75. (Pubitemid 44401894)
20. Sommer U, Costello CE, Hayes GR, et al. Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells. J Biol Chem 2005;280(25):23853-60. (Pubitemid 40884872)
21. Yadav M, Dubey ML, Gupta I, Malla N. Cysteine proteinase 30 (CP30) and antibody response to CP30 in serum and vaginal washes of symptomatic and asymptomatic Trichomonas vaginalis infected women. Parasite Immunol 2007;29:359-65. (Pubitemid 46944446)
22. Alderete JF, Benchimol M, Lehker MW, et al. The complex fibronectin-Trichomonas vaginalis interactions and Trichomonosis. Parasitol Int 2002;51(3):285-92. (Pubitemid 35335301)
23. Crouch ML, Benchimol M, Alderete JF. Binding of fibronectin by Trichomonas vaginalis is influenced by iron and calcium. Microb Pathog 2001;31(3):131-44. (Pubitemid 32783432)
24. Lubick KJ, Burgess DE. Purification and analysis of a phospholipase A2-like lytic factor of Trichomonas vaginalis. Infect Immun 2004;72(3):1284-90. (Pubitemid 38263746)
25. Kucknoor AS, Mundodi V, Alderete JF. The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65. Cell Microbiol 2007;9(11):2586-97. (Pubitemid 47500512)
26. Hsu H-M, Ong S-J, Lee M-C, Tai J-H. Transcriptional regulation of an iron-inducible gene by differential and alternate promoter entries of multiple Myb proteins in the protozoan parasite Trichomonas vaginalis. Eukaryot Cell 2009;8(3):362-72.
27. León-Sicairos CR, León-Félix J, Arroyo R. tvcp12: a novel Trichomonas vaginalis cathepsin L-like cysteine proteinase-encoding gene. Microbiology 2004;150: 1131-8. (Pubitemid 38744712)
28. Singh BN, Hayes GR, Lucas JJ, et al. Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function. Glycoconj J 2009;26:3-17.
29. Yadav M, Gupta I, Malla N. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response. Parasite Immunol 2005;27:461-7.
30. Fichorova RN. Impact of T. vaginalis infection on innate immune responses and reproductive outcome. J Reprod Immunol 2009;83:185-9.
31. Than NG, Kim SS, Abbas A, et al. Chorioamnionitis and increased galectin-1 expression in PPROM-an anti-inflammatory response in the fetal membranes? Am J Reprod Immunol 2008;60:298-311.
32. Than NG, Erez O, Wildman DE, et al. Severe preeclampsia is characterized by increased placental expression of galectin-1. J Matern Fetal Neonatal Med 2008;21:429-42. (Pubitemid 352000663)
33. Schwebke JR, Hook 3rd EW. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 2003;188(3):465-8. (Pubitemid 36960659)
34. Soper D. Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 2004;190(1):281-90.
35. Weinstock H, Berman S, Cates Jr W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6-10.
36. Huppert JS, Mortensen JE, Reed JL, et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 2007;45(2): 194-8. (Pubitemid 47041010)
37. Lowe NK, Neal JL, Ryan-Wenger NA. Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard. Obstet Gynecol 2009;113(1):89-95.
38. AslanDL, GulbahceHE, StelowEB, et al. The diagnosis of Trichomonas vaginalis in liquid-based Pap tests: correlationwith PCR.Diagn Cytopathol 2005;32(6):341-4.
39. Huppert JS, Batteiger BE, Braslins P, et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol 2005;43(2):684-7. (Pubitemid 40256019)
40. Hardick A, Hardick J, Wood BJ, et al. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche Light- Cycler instrument with female self-obtained vaginal swab samples and male urine samples. J Clin Microbiol 2006;44(11):4197-9. (Pubitemid 44737270)
41. Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J ClinMicrobiol 2006;44(2):366-73. (Pubitemid 43222224)
42. Sena AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007;44:13-22. (Pubitemid 44968978)
43. Centers forDisease ControlandPrevention,WorkowskiKA,BermanSM.Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2006;55(August (RR-11)):1-94. Erratum in: MMWR Recomm Rep 2006;55(September (36)):997.
44. Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 2010;50(Suppl 1):S16-23.
45. Cudmore SL, Delgaty KL, Hayward-McClelland SF, et al. Treatment of infections caused by metronidazole-resistance Trichomonas vaginalis. Clin Microbiol Rev 2004;17(4):783-93. (Pubitemid 39372517)
46. Das S, Huengsberg M, Shahmanesh M. Treatment failure of vaginal trichomoniasis in clinical practice. Int J STD AIDS 2005;16(4):284-6. (Pubitemid 40676404)